Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33


Oncologic Outcomes of Adjuvant versus Salvage Radiotherapy after Prostatectomy.

Seddik S, Silva M, Dugué AE, Ait Said K, Joly F, Tillou X.

Urol Int. 2019 Jun 21:1-7. doi: 10.1159/000501086. [Epub ahead of print]


Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program.

Dos Santos M, Lequesne J, Dugué AE, Grellard JM, Ory C, Jaffré S, Lavergne K, Lelaidier A, Laroche L, Divanon F, Delcambre C, Galais MP, Clarisse B, Faveyrial A.

Eur J Cancer Care (Engl). 2019 May;28(3):e13015. doi: 10.1111/ecc.13015. Epub 2019 Feb 20.


Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.

Johnson AC, Matias M, Boyle H, Escudier B, Molinier A, Laguerre B, Helissey C, Brachet PE, Dugué AE, Mourey L, Coquan E, Joly F.

BMC Cancer. 2017 May 22;17(1):355. doi: 10.1186/s12885-017-3312-7.


Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.

Rambeau A, Gervais R, De Raucourt D, Babin E, Dugué AE, Florescu C, Blanchard D, Gery B.

Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2883-2889. doi: 10.1007/s00405-017-4550-7. Epub 2017 Apr 5.


BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer.

Jamard E, Volard B, Dugué AE, Legros A, Leconte A, Clarisse B, Davy G, Polycarpe F, Dugast C, Abadie C, Frebourg T, Tinat J, Tennevet I, Layet V, Joly F, Castéra L, Berthet P, Vaur D, Krieger S.

Fam Cancer. 2017 Apr;16(2):167-171. doi: 10.1007/s10689-016-9940-2.


Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Dupont B, Mariotte D, Dugué AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpé S, Moldovan C, Bouhier-Leporrier K, Reimund JM, Di Fiore F, Zanetta S, Mailliez A, Do P, Peytier A, Galais MP, Florescu C, Schott R, Le Mauff B, Gervais R.

Br J Clin Pharmacol. 2017 Mar;83(3):623-631. doi: 10.1111/bcp.13140. Epub 2016 Oct 24.


How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software.

Dugué AE, Pulido M, Chabaud S, Belin L, Gal J.

Clin Cancer Res. 2016 Dec 1;22(23):5629-5635. Epub 2016 Sep 23.


Corrigendum: Unique human orbital morphology compared with that of apes.

Denion E, Hitier M, Guyader V, Dugué AE, Mouriaux F.

Sci Rep. 2016 Jul 20;6:29861. doi: 10.1038/srep29861. No abstract available.


Sense and sensibility to early combine bevacizumab to radiation treatment of brain metastasis: reply to Lou and Sperduto.

Lévy C, Dugué AE, Clarisse B.

Ann Transl Med. 2016 Apr;4(7):148. doi: 10.21037/atm.2016.03.41. No abstract available.


Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.

How Kit N, Dugué AE, Sevin E, Allouache N, Lesaunier F, Joly F, Aide N.

Nucl Med Commun. 2016 Apr;37(4):348-55. doi: 10.1097/MNM.0000000000000457.


Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?

Lasnon C, Dugué AE, Briand M, Dutoit S, Aide N.

EJNMMI Res. 2015 Dec;5(1):61. doi: 10.1186/s13550-015-0141-z. Epub 2015 Nov 5.


REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

Lévy C, Allouache D, Lacroix J, Dugué AE, Supiot S, Campone M, Mahe M, Kichou S, Leheurteur M, Hanzen C, Dieras V, Kirova Y, Campana F, Le Rhun E, Gras L, Bachelot T, Sunyach MP, Hrab I, Geffrelot J, Gunzer K, Constans JM, Grellard JM, Clarisse B, Paoletti X.

Ann Oncol. 2015 Nov;26(11):2359. doi: 10.1093/annonc/mdv386. No abstract available.


How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.

Vanbockstael J, Coquan E, Gouerant S, Allouache D, Faveyrial A, Noal S, Delcambre C, Galais MP, Héron JF, Lefebvre AC, Sevin E, Hrab I, Polycarpe F, André M, Kaluzinski L, Gervais R, Gunzer K, Vié B, Saucier G, Lemenand N, Grellard JM, Clarisse B, Dugué AE, Joly F.

Support Care Cancer. 2016 Mar;24(3):1131-8. doi: 10.1007/s00520-015-2882-7. Epub 2015 Aug 14.


Unique human orbital morphology compared with that of apes.

Denion E, Hitier M, Guyader V, Dugué AE, Mouriaux F.

Sci Rep. 2015 Jun 25;5:11528. doi: 10.1038/srep11528. Erratum in: Sci Rep. 2016 Jul 20;6:29861.


Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting.

Sassier M, Dugué AE, Clarisse B, Lesueur P, Avrillon V, Bizieux-Thaminy A, Auliac JB, Kaluzinski L, Tillon J, Robinet G, Le Caer H, Monnet I, Madroszyk A, Boza G, Falchero L, Fournel P, Egenod T, Toffart AC, Leiber N, Do P, Gervais R.

Lung Cancer. 2015 Aug;89(2):161-6. doi: 10.1016/j.lungcan.2015.05.005. Epub 2015 May 15.


NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System.

Lasnon C, Dugue AE, Briand M, Blanc-Fournier C, Dutoit S, Louis MH, Aide N.

Mol Imaging Biol. 2015 Jun;17(3):403-12. doi: 10.1007/s11307-014-0805-5.


REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.

Lévy C, Allouache D, Lacroix J, Dugué AE, Supiot S, Campone M, Mahe M, Kichou S, Leheurteur M, Hanzen C, Dieras V, Kirova Y, Campana F, Le Rhun E, Gras L, Bachelot T, Sunyach MP, Hrab I, Geffrelot J, Gunzer K, Constans JM, Grellard JM, Clarisse B, Paoletti X.

Ann Oncol. 2014 Dec;25(12):2351-6. doi: 10.1093/annonc/mdu465. Epub 2014 Oct 1. Erratum in: Ann Oncol. 2015 Nov;26(11):2359.


Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: an ex vivo experiment in human serous ovarian carcinoma.

Lheureux S, N'Diaye M, Blanc-Fournier C, Dugué AE, Clarisse B, Dutoit S, Giffard F, Abeilard E, Briand M, Labiche A, Grellard JM, Crouet H, Martin S, Joly F, Poulain L.

Int J Cancer. 2015 Mar 1;136(5):E340-50. doi: 10.1002/ijc.29104. Epub 2014 Aug 8.


Diagnostic value of three-dimensional contrast-enhanced echocardiography for left ventricular volume and ejection fraction measurement in patients with poor acoustic windows: a comparison of echocardiography and magnetic resonance imaging.

Saloux E, Labombarda F, Pellissier A, Anthune B, Dugué AE, Provost N, Allain P, De Craene M, Milliez P, Manrique A.

J Am Soc Echocardiogr. 2014 Oct;27(10):1029-40. doi: 10.1016/j.echo.2014.06.006. Epub 2014 Jul 23.


Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

Bellevre D, Blanc Fournier C, Switsers O, Dugué AE, Levy C, Allouache D, Desmonts C, Crouet H, Guilloit JM, Grellard JM, Aide N.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1103-12. doi: 10.1007/s00259-014-2689-7. Epub 2014 Feb 22.


Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.

Alexandre J, Saloux E, Lebon A, Dugué AE, Lemaitre A, Roule V, Labombarda F, Champ-Rigot L, Gomes S, Pellissier A, Scanu P, Milliez P.

Europace. 2014 Feb;16(2):220-6. doi: 10.1093/europace/eut289. Epub 2013 Nov 1.


Sunglasses with thick temples and frame constrict temporal visual field.

Denion E, Dugué AE, Augy S, Coffin-Pichonnet S, Mouriaux F.

Optom Vis Sci. 2013 Dec;90(12):1450-5. doi: 10.1097/OPX.0000000000000081.


[Obstetric data in a population with postural changes during labor and delivery].

Lepleux F, Hue B, Dugué AE, Six T, Riou C, Dreyfus M.

J Gynecol Obstet Biol Reprod (Paris). 2014 Sep;43(7):504-13. doi: 10.1016/j.jgyn.2013.06.013. Epub 2013 Aug 22. French.


Eye motion increases temporal visual field extent.

Denion E, Dugué AE, Coffin-Pichonnet S, Augy S, Mouriaux F.

Acta Ophthalmol. 2014 May;92(3):e200-6. doi: 10.1111/aos.12106. Epub 2013 Apr 16.


Rotational atherectomy for left main coronary artery disease in octogenarians: transradial approach in a tertiary center and literature review.

Dahdouh Z, Roule V, Dugué AE, Sabatier R, Lognoné T, Grollier G.

J Interv Cardiol. 2013 Apr;26(2):173-82. doi: 10.1111/joic.12026. Review. Erratum in: J Interv Cardiol. 2013 Jun;26(3):317.


Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.

Alexandre J, Saloux E, Dugué AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P.

J Cardiovasc Magn Reson. 2013 Jan 19;15:12. doi: 10.1186/1532-429X-15-12.


[Inferior alveolar nerve block with ropivacaine: effect on nausea and vomiting after mandibular osteotomy].

Chatellier A, Dugué AE, Caufourier C, Maksud B, Compère JF, Bénateau H.

Rev Stomatol Chir Maxillofac. 2012 Dec;113(6):417-22. doi: 10.1016/j.stomax.2012.10.003. Epub 2012 Nov 16. French.


Alterations of left ventricular myocardial strain in obese children.

Labombarda F, Zangl E, Dugue AE, Bougle D, Pellissier A, Ribault V, Maragnes P, Milliez P, Saloux E.

Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):668-76. doi: 10.1093/ehjci/jes238. Epub 2012 Nov 15.


Viral epidemiology and severity of respiratory infections in infants in 2009: a prospective study.

Laurent C, Dugué AE, Brouard J, Nimal D, Dina J, Parienti JJ, Vabret A.

Pediatr Infect Dis J. 2012 Aug;31(8):827-31. doi: 10.1097/INF.0b013e3182566005.


O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.

Lechapt-Zalcman E, Levallet G, Dugué AE, Vital A, Diebold MD, Menei P, Colin P, Peruzzy P, Emery E, Bernaudin M, Chapon F, Guillamo JS.

Cancer. 2012 Sep 15;118(18):4545-54. doi: 10.1002/cncr.27441. Epub 2012 Feb 22.


Vascular access sites for acute renal replacement in intensive care units.

Dugué AE, Levesque SP, Fischer MO, Souweine B, Mira JP, Megarbane B, Daubin C, du Cheyron D, Parienti JJ; Cathedia Study Group.

Clin J Am Soc Nephrol. 2012 Jan;7(1):70-7. doi: 10.2215/CJN.06570711. Epub 2011 Nov 10.


Continuous renal replacement therapy may increase the risk of catheter infection.

Parienti JJ, Dugué AE, Daurel C, Mira JP, Mégarbane B, Mermel LA, Daubin C, du Cheyron D; Members of the Cathedia Study Group.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1489-96. doi: 10.2215/CJN.02130310. Epub 2010 Jun 17.

Supplemental Content

Loading ...
Support Center